nonacog alfa Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
blood factor IX 5163 181054-95-5

Description:

MoleculeDescription

Synonyms:

  • nonacog alfa
  • recombinant coagulation factor IX
Coagulation Factor IX Recombinant Human
  • Molecular weight:
  • Formula:
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA:
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
Aug. 27, 1997 EMA Pfizer Ltd

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

Pharmacologic Action:

None

Drug Use (View source of the data)

DiseaseRelationSNOMED_IDDOID
Hereditary factor IX deficiency disease indication 41788008 DOID:12259

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
4021022 VANDF
C2826076 UMLSCUI
CHEMBL2109205 ChEMBL_ID
CHEMBL4298080 ChEMBL_ID
DB00100 DRUGBANK_ID
1300488 RXNORM
22458 MMSL
016050 NDDF
395860001 SNOMEDCT_US
415245003 SNOMEDCT_US
425189006 SNOMEDCT_US
781164006 SNOMEDCT_US

Pharmaceutical products:

None